In a significant strategic shift, Hut 8 Corp. is decommissioning a key mining site and redirecting capital toward AI and high-performance computing infrastructure, signaling a move to diversify beyond volatile cryptocurrency markets.
Terex Corporation's shares have experienced notable swings, declining over 4% last week but gaining nearly 7% in the past month. A fresh look at its valuation through discounted cash flow and peer comparisons suggests the stock may be trading at a significant discount to its intrinsic value.
Despite a robust drug pipeline and steady long-term gains, AstraZeneca's recent share price stagnation has investors questioning its true worth. A deep dive into valuation models suggests the pharmaceutical giant may be trading at a significant discount to its intrinsic value, even as its P/E ratio appears elevated compared to peers.
Imperial Oil Ltd. reported robust fourth-quarter results, generating nearly $1.4 billion in free cash flow and announcing its largest-ever nominal dividend increase. Despite weather disruptions at its Kearl oil sands operation, the company highlighted record annual production and a disciplined capital return strategy that saw $4.6 billion returned to shareholders in 2025.
ExxonMobil's 2025 year-end results underscore a reshaped corporate strategy, delivering record shareholder returns and production milestones in Guyana and the Permian, while advancing carbon capture and enterprise digitalization.
Despite posting a quarterly loss in its core wood products unit amid 'extremely challenging' markets, Weyerhaeuser closed 2025 with strategic pivots. The forestry giant is doubling down on its land management and nascent 'Climate Solutions' business, while managing a disciplined capital return to shareholders.
Expedia Group shares have rallied impressively over the past year, leaving investors to question if the opportunity has passed. A deep dive into valuation metrics suggests the online travel giant may still be trading at a discount, despite its recent run-up.
Construction giant Skanska has secured a landmark joint venture for a central Oslo redevelopment with Entra, alongside new major contracts in Norway and Finland, reinforcing its strategic pivot towards complex, sustainability-focused projects in the region.
Medtronic's expanded partnership with Mindray integrates its monitoring technologies into ASC-focused platforms, a strategic move to embed itself in a high-growth segment while analysts debate its impact on the broader investment thesis.
A Memphis couple's financial foundation is shaken after the husband secretly buys a high-value investment property, sparking a fierce debate on trust, communication, and 'financial infidelity' in marriage.
Expedia Group's latest quarterly results, surpassing expectations across key metrics, have reignited investor interest and a fierce debate over its true worth. While analysts see room for growth, looming challenges in travel demand and disruptive AI search tools cloud the horizon.
Truist Financial taps debt markets with a multi-billion dollar issuance, aiming to strengthen its funding base while sustaining shareholder returns amidst a shifting interest rate landscape.
Boeing reports a surge in orders and finalizes its Spirit AeroSystems buyout, aiming to solidify its supply chain. However, ongoing production challenges and regulatory scrutiny cast a shadow over its ambitious ramp-up plans.
As SpaceX nears a deal to acquire xAI, analysts see a straightforward step in Elon Musk's grand vision. However, integrating the publicly traded Tesla into a sprawling 'Musk Inc.' conglomerate presents a far more complex financial and regulatory challenge for investors.
Despite a new U.S. framework for involvement, extracting Greenland's rare earth metals is hampered by Arctic extremes, local political opposition, and strained transatlantic ties.
Despite political pressure and vast reserves, U.S. oil majors ExxonMobil and Chevron are taking a cautious stance on new spending in Venezuela, demanding legal stability and fiscal reforms before committing fresh capital, even as they signal long-term interest.
Merck & Co. shifts its cancer drug development playbook, opting for targeted collaborations with Guardant Health and Eikon Therapeutics after walking away from a major acquisition. Analysts debate whether the stock's current price fully reflects its long-term pipeline potential.
Apple's stock faces pressure from rising component costs even after a blockbuster Q1 fueled by iPhone demand. JPMorgan analysts see the pullback as a chance to buy, citing a discounted valuation and long-term AI and services growth drivers.
Apple shares edged higher following a robust Q1 earnings report headlined by record iPhone revenue, yet the muted gains reflect Wall Street's growing focus on looming supply constraints and the company's strategic pivot to artificial intelligence.
Recent buying activity by multiple executives at AdNeo Limited suggests internal optimism about the company's trajectory, even as its stock trades below their purchase price.
